Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01786525 · ClinicalTrials.gov registry record · NA

House Calls and Decision Support: Improving Access to Live Donor Transplantation

A NA study, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
109
Enrollment target

NCT01786525: Completed NA study, sponsored by Beth Israel Deaconess Medical Center.

NCT01786525 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 109 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01786525, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target

Study Summary

The main purpose of this research program is to reduce the burden of end-stage organ disease on individuals, families, healthcare systems, and society by increasing the availability of donor organs for transplantation. Consistent with this aim, the project further examines strategies to increase access to and reduce disparities - racial, economic, gender - in live donor kidney transplantation (LDKT). Specifically, we expand the research and intensity of an innovative House Calls intervention developed by the principal investigator by including other minorities and socioeconomically disadvantaged patients and by adding a novel Patient-Centered Decision Support component. The main study hypothesis is that participants receiving the novel intervention (House Calls + Patient-Centered Decision Support) will have a higher proportion of LDKT's by the 2-year study endpoint.

Interventions

  • BEHAVIORAL House Calls
  • BEHAVIORAL Web-Based Patient-Centered Decision Support Intervention

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2013-06
Est. Completion 2020-05-31
Phase NA

What the finished NCT01786525 record still lists

NCT01786525 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which House Calls is the first listed.

NCT01786525 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01786525 about?

NCT01786525 is a clinical study titled "House Calls and Decision Support: Improving Access to Live Donor Transplantation". The main purpose of this research program is to reduce the burden of end-stage organ disease on individuals, families, healthcare systems, and society by increasing the availability of donor organs for transplantation. Consistent with this aim, the project further examines strategies to increase acc...

What is the current status of trial NCT01786525?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2013-06. Estimated completion is 2020-05-31.

What interventions are being tested in trial NCT01786525?

The interventions under investigation include: House Calls (BEHAVIORAL), Web-Based Patient-Centered Decision Support Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01786525?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01786525's enrollment target sits among peer trials

109 825th of 2000 higher than 1,176 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01786525, the US trial registry maintained by the National Library of Medicine. NCT01786525 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.